Ottawa, Ontario, Canada Ocular Mobile Innovations Inc. (OMI), a Canadian digital health and life-sciences company, is developing portable, non-invasive optical screening technologies that directly address global health inequities while offering a scalable, commercialization-driven investment opportunity aligned with Environmental, Social, and Governance (ESG) and impact-investment mandates.
Founded in 2016, OMI’s mission centers on expanding access to early vision and neurological screening by enabling decentralized, point-of-care diagnostics outside traditional clinical settings. The company’s approach supports preventative healthcare delivery, cost reduction, and improved long-term outcomes core priorities for governments, insurers, employers, and global health organizations.
Social Impact: Expanding Access to Preventive Healthcare
Uncorrected vision impairment and undiagnosed neurological conditions disproportionately affect children, aging populations, and underserved communities. OMI’s technology platform is designed to enable early detection at scale, supporting:
Vision screening in schools and community programs
Early identification of neurological impairment and brain trauma
Occupational health and safety monitoring for fatigue and impairment
Improved access to screening in remote and resource-limited regions
By enabling fast, non-contact screenings, OMI contributes to health equity, productivity, and quality of life, while reducing downstream healthcare costs.
Environmental Responsibility: Efficient, Low-Resource Screening
OMI’s mobile devices are designed to minimize environmental impact by:
Reducing dependence on large, energy-intensive clinical equipment
Limiting unnecessary patient travel through decentralized screening
Supporting digital data capture and analysis, reducing paper-based workflows
These efficiencies align with sustainability objectives by lowering the carbon footprint associated with traditional diagnostic pathways.
Governance & Responsible Innovation
Ocular Mobile Innovations is guided by an experienced leadership team with expertise in optical engineering, healthcare innovation, commercialization, and corporate governance. The company emphasizes:
Ethical use of health data and privacy-conscious design
Transparent corporate governance and accountability
Alignment with regulatory standards and responsible innovation frameworks
OMI’s governance approach supports investor confidence while ensuring long-term, sustainable value creation.
Scalable Business Model with Measurable Impact
OMI’s technology platform is designed for deployment across multiple sectors, supporting scalable revenue models through:
Device sales and deployment partnerships
Licensing and service agreements
Public-private collaborations and institutional adoption
Impact outcomes can be measured through screenings conducted, populations reached, early detections enabled, and healthcare cost reductions, enabling alignment with UN Sustainable Development Goals (SDGs) — particularly SDG 3: Good Health and Well-Being and SDG 10: Reduced Inequalities.
Investment Thesis
Ocular Mobile Innovations offers impact-oriented investors exposure to:
A growing global preventive healthcare market
Proprietary, non-invasive screening technology
Strong alignment with ESG and impact-measurement frameworks
Potential for attractive financial returns alongside measurable social benefit
The company is actively engaging with strategic and impact-focused investors to accelerate product validation, regulatory advancement, and market entry.
Fatigue has been attributed as a significant cause of accidents and a substantial risk for public safety. More than 20% of accidents are attributed to driver fatigue.
(2016 study by the Federal Motor Carrier Safety Administration (FMCSA) and supported by Transport Canada)
Fatigue is also recognized as a significant workplace hazard by the Canadian Centre for Occupational Health and Safetyhttps://www.ccohs.ca/oshanswers/psychosocial/fatigue.html. Research has shown that the effects of fatigue on cognitive performance are comparable to alcohol (i.e. 21 hours of wakefulness is equivalent to a blood alcohol content of 0.08). It is estimated that fatigue in the workplace is costing more than 18 billion a year in the US. (Industrial Psychiatry, 2015, Fatigue management in the workplace).
With DetectVueTM, there is now a reliable device that can measure the cognitive losses resulting from fatigue.
Keep your workplace safe with rapid eye response screening. Learn more about Ocular Mobile’s eye screening technology to enhance your company’s health, safety, and wellness program.
Access to vision screening
According to the World Health Organization, approximately 19 million children under the age of 15 years have one or more vision impairments. While it may not seem like much, this stat only confirms those who were screened. How about the children who didn’t have access to vision screening?
World Health Organization. Visual impairment and blindness [Internet]. Geneva: World Health Organization; c2015.
Some studies have reported that North American vision testing frequency is inconsistent and not offered in all communities, and protocol standards are not followed for all ages. Rates are found to be significantly lower in remote communities and developing countries.
Vision screening: a critical visual health measure
Our mobile, hand-held screening device VisionVue will support health and school officials in conducting crucial eye screenings in minutes within a classroom for early detection of eye conditions that can impact a child’s visual and general development. Currently, there is no universal and accessible plan for testing, leaving many children at risk for permanent vision loss.
In recent years, health officials travel to schools in urban areas hauling large pieces of equipment to test the eyes of students at school. The World Health Organization protocol recommends yearly screening of children until the age of 19 years old. Until now, there was no integrative technology that could screen for risk factors and visual problems.
Many children are not getting screened for treatable conditions such as myopia and anisometropia which can lead to major long-term issues like amblyopia.
DetectVueTM will bring technology to the classroom in the form of a small device equipped with visual imagery that captures the attention of a child while an assessment is taking place – in less than 2 minutes. Our portable vision screener makes eye screening easy, fast and reliable, anywhere in the world.
Adults and remote communities matter too!
For adults with disabilities, elderly individuals living in retirement homes or long-term care facilities, many do not have the means, mobility or resources to have their eyes screened regularly. Afterall, an eye exam is a costly proposal if you don’t have a private insurance plan.
If individuals live in remote or rural communities, access to eye screening technology is not universally available. Through our cloud technology, we are moving ocular testing from professional offices to where people are, regardless of their location in the world. With VisionVueTM, people will get their eyes screened, monitored for changes or treatment follow up in community centers, schools, long-term care facilities or retirement homes.
“OMI’s second-generation technology goes beyond current screening with new multi-dimensional screening capabilities.”
It not only increases the number of tests that can be conducted but captures more than 600 data points on fewer images resulting in precise, data for the screening of a broader range of conditions such as risk factors for diabetic retinopathy, or a disease known as age-related macular degeneration (AMD) and more. VisionVue with revolutionary algorithms is designed to screen more conditions than any device in the market.
Réjean Munger, PhD
CEO
Ocular Mobile Innovations Inc.
613.797.1827 | e: r.munger@ocularmobile.com
wocularmobile.com
